These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 8396437)

  • 1. Prophylaxis and management of cytomegalovirus pneumonitis after lung transplantation: a review of experience in one center.
    Gould FK; Freeman R; Taylor CE; Ashcroft T; Dark JH; Corris PA
    J Heart Lung Transplant; 1993; 12(4):695-9. PubMed ID: 8396437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of ganciclovir prophylaxis on heart-lung and lung transplant recipients.
    Soghikian MV; Valentine VG; Berry GJ; Patel HR; Robbins RC; Theodore J
    J Heart Lung Transplant; 1996 Sep; 15(9):881-7. PubMed ID: 8889983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ganciclovir prophylaxis for cytomegalovirus infection in pediatric allogeneic bone marrow transplant recipients.
    Canpolat C; Culbert S; Gardner M; Whimbey E; Tarrand J; Chan KW
    Bone Marrow Transplant; 1996 Apr; 17(4):589-93. PubMed ID: 8722360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ganciclovir for cytomegalovirus: a call for indefinite prophylaxis in lung transplantation.
    Valentine VG; Weill D; Gupta MR; Raper B; Laplace SG; Lombard GA; Bonvillain RW; Taylor DE; Dhillon GS
    J Heart Lung Transplant; 2008 Aug; 27(8):875-81. PubMed ID: 18656801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytomegalovirus infection in isolated lung transplantations.
    Maurer JR; Tullis DE; Scavuzzo M; Patterson GA
    J Heart Lung Transplant; 1991; 10(5 Pt 1):647-9. PubMed ID: 1659900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized trial of daily versus three-times-weekly prophylactic ganciclovir after lung and heart-lung transplantation.
    Hertz MI; Jordan C; Savik SK; Fox JM; Park S; Bolman RM; Dosland-Mullan BM
    J Heart Lung Transplant; 1998 Sep; 17(9):913-20. PubMed ID: 9773865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extended ganciclovir prophylaxis in lung transplantation.
    Perreas KG; McNeil K; Charman S; Sharples LD; Wreghitt T; Wallwork J
    J Heart Lung Transplant; 2005 May; 24(5):583-7. PubMed ID: 15896756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of human cytomegalovirus infection and disease after allogeneic bone marrow transplantation.
    Stocchi R; Ward KN; Fanin R; Baccarani M; Apperley JF
    Haematologica; 1999 Jan; 84(1):71-9. PubMed ID: 10091394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of cytomegalovirus match on survival after cardiac and lung transplantation.
    Bonatti H; Tabarelli W; Ruttmann E; Kafka R; Larcher C; Höfer D; Klaus A; Laufer G; Geltner C; Margreiter R; Müller L; Antretter H
    Am Surg; 2004 Aug; 70(8):710-4. PubMed ID: 15328806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preemptive therapy with intravenous ganciclovir for the prevention of cytomegalovirus disease in lung transplant recipients.
    Monforte V; Román A; Gavaldà J; Bravo C; Gispert P; Pahissa A; Morell F
    Transplant Proc; 2005 Nov; 37(9):4039-42. PubMed ID: 16386621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delay of CMV infection in high-risk CMV mismatch lung transplant recipients due to prophylaxis with oral ganciclovir.
    Palmer SM; Grinnan DC; Diane Reams B; Steele MP; Messier RH; Duane Davis R
    Clin Transplant; 2004 Apr; 18(2):179-85. PubMed ID: 15016133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CMV antigenemia (the lower matrix protein PP65), a marker for the guidance of antiviral therapy in cytomegalovirus disease after orthotopic heart transplantation.
    Iberer F; Tscheliessnigg KH; Halwachs G; Auer T; Wasler A; Petutschnigg B; Müller H; Freigassner M; Allmayr T; Hipmair G
    Wien Klin Wochenschr; 1995; 107(23):718-22. PubMed ID: 8560893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of primary cytomegalovirus disease in organ transplant recipients with oral ganciclovir or oral acyclovir prophylaxis.
    Rubin RH; Kemmerly SA; Conti D; Doran M; Murray BM; Neylan JF; Pappas C; Pitts D; Avery R; Pavlakis M; Del Busto R; DeNofrio D; Blumberg EA; Schoenfeld DA; Donohue T; Fisher SA; Fishman JA
    Transpl Infect Dis; 2000 Sep; 2(3):112-7. PubMed ID: 11429021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Ganciclovir prophylaxis for cytomegalovirus interstitial pneumonitis after allogeneic bone marrow transplantation].
    Sakai R; Maruta A; Taguchi J; Tomita N; Fujita H; Kodama F; Ogawa K; Fujisawa S; Matsuzaki M; Motomura S; Okubo T
    Rinsho Ketsueki; 1996 Jan; 37(1):14-21. PubMed ID: 8683862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Value of a short (7 days) prophylactic course of ganciclovir in the prevention of cytomegalovirus disease after heart transplantation].
    Giménez D; María Arizón J; de la Torre J; Anguita M; Escauriaza J; López Granados A; Mesa D; Torres F; Casares J; Concha M; Vallés F
    Rev Esp Cardiol; 1996 Jan; 49(1):35-40. PubMed ID: 8685510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytomegalovirus prophylaxis with ganciclovir in kidney transplant recipients receiving induction antilymphocyte antibodies.
    Said T; Nampoory MR; Johny KV; Pacsa AS; Mini Abraham P; Nair MP; Abdel-Haleem M; Samhan M; Al-Mousawi M
    Transplant Proc; 2004; 36(6):1847-9. PubMed ID: 15350495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single lung transplantation. Factors in postoperative cytomegalovirus infection.
    Calhoon JH; Nichols L; Davis R; Bryant CL; Levine SM; Zamora CA; Anzueta A; Lum CT; Grover FL; Trinkle JK
    J Thorac Cardiovasc Surg; 1992 Jan; 103(1):21-5; discussion 25-6. PubMed ID: 1309466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined CMV prophylaxis improves outcome and reduces the risk for bronchiolitis obliterans syndrome (BOS) after lung transplantation.
    Ruttmann E; Geltner C; Bucher B; Ulmer H; Höfer D; Hangler HB; Semsroth S; Margreiter R; Laufer G; Müller LC
    Transplantation; 2006 May; 81(10):1415-20. PubMed ID: 16732179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cytomegalovirus infection in lung transplantation; current status, detection, prophylactic treatment].
    Aoe M; Tao H; Yamane M; Toyooka S; Sano Y; Okazaki M; Date H
    Kyobu Geka; 2007 Oct; 60(11):988-92. PubMed ID: 17926902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized clinical trial of ganciclovir vs acyclovir for prevention of cytomegalovirus antigenemia after allogeneic transplantation.
    Burns LJ; Miller W; Kandaswamy C; DeFor TE; MacMillan ML; Van Burik JA; Weisdorf DJ
    Bone Marrow Transplant; 2002 Dec; 30(12):945-51. PubMed ID: 12476289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.